IQVIA Holdings (IQV) Stock Forecast & Price Target

Compare

1,020 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IQV Analyst Ratings

Strong Buy

12 Buy

4 Hold

0 Sell

Based on 16 analysts giving stock ratings to

IQVIA

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IQV Stock 12 Month Forecast

Average Price Target

$232.21

▲(40.21% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for IQVIA Holdings in the last 3 months. The average price target is $232.21 with a high forecast of $266.00 and a low forecast of $174.00. The average price target represents a 40.21% change from the last price of $165.62.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"138":"$138","267":"$267","170.25":"$170.3","202.5":"$202.5","234.75":"$234.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":266,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$266.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":232.21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$232.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":174,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$174.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[138,170.25,202.5,234.75,267],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,231.23,233.90461538461537,236.57923076923075,239.25384615384615,241.92846153846153,244.6030769230769,247.2776923076923,249.9523076923077,252.62692307692308,255.30153846153846,257.97615384615386,260.65076923076924,263.3253846153846,{"y":266,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,231.23,231.3053846153846,231.38076923076923,231.45615384615385,231.53153846153845,231.60692307692307,231.6823076923077,231.7576923076923,231.83307692307693,231.90846153846155,231.98384615384614,232.05923076923077,232.1346153846154,{"y":232.21,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,231.23,226.8276923076923,222.42538461538462,218.02307692307693,213.6207692307692,209.21846153846153,204.81615384615384,200.41384615384615,196.01153846153846,191.60923076923075,187.2069230769231,182.80461538461537,178.4023076923077,{"y":174,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":201.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":139.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.61,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":182.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.46,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.47,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":225.41,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$266.00

Average Price Target$232.21

Lowest Price Target$174.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jailendra Singh

Truist Financial

$290→$245

Buy

47.93%

Upside

Reiterated

02/19/26

Truist Financial Sticks to Its Buy Rating for IQVIA Holdings (IQV)

Charles Rhyee

TD Cowen

$245→$174

Hold

5.06%

Upside

Reiterated

02/13/26

IQVIA: Solid 2026 Outlook but AI Disruption Risks Justify Hold Rating and Lowered Valuation

Kallum Titchmarsh

Morgan Stanley

$265→$240

Buy

44.91%

Upside

Reiterated

02/11/26

Iqvia price target lowered to $240 from $265 at Morgan StanleyIqvia price target lowered to $240 from $265 at Morgan Stanley

Sean Dodge

BMO Capital

$250

Buy

50.95%

Upside

Reiterated

02/09/26

Analysts' Top Healthcare Picks: Haemonetics (HAE), Waters (WAT)

David Windley

Jefferies

$255

Buy

53.97%

Upside

Reiterated

02/06/26

Jefferies Reaffirms Their Buy Rating on IQVIA Holdings (IQV)

Dan Leonard

UBS

$280→$240

Buy

44.91%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $240 from $280 at UBSIqvia price target lowered to $240 from $280 at UBS

Shlomo Rosenbaum

Stifel Nicolaus

$273→$220

Buy

32.83%

Upside

Reiterated

02/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (NYSE: IQV), Qiagen (NYSE: QGEN) and Ligand Pharma (NASDAQ: LGND)

Patrick B Donnelly

Citi

$230→$200

Hold

20.76%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $200 from $230 at CitiIqvia price target lowered to $200 from $230 at Citi

Michael Ryskin

Bank of America Securities

$245

Buy

47.93%

Upside

Reiterated

02/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (NYSE: IQV), Ocular Therapeutix (NASDAQ: OCUL) and Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Anne Samuel

J.P. Morgan

$255→$225

Buy

35.85%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $225 from $255 at JPMorganIqvia price target lowered to $225 from $255 at JPMorgan

Luke Sergott

Barclays

$230→$210

Hold

26.80%

Upside

Reiterated

02/06/26

Barclays Keeps Their Hold Rating on IQVIA Holdings (IQV)

Elizabeth Anderson CFA

Evercore ISI

$250→$225

Buy

35.85%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $225 from $250 at Evercore ISIIqvia price target lowered to $225 from $250 at Evercore ISI

Max Smock

William Blair

Buy

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Omnicell (NASDAQ: OMCL) and MiMedx Group (NASDAQ: MDXG)

David Larsen

BTIG

Hold

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Haemonetics (NYSE: HAE) and Denali Therapeutics (NASDAQ: DNLI)

Ann Hynes

Mizuho Securities

$250→$266

Buy

60.61%

Upside

Reiterated

01/09/26

Iqvia price target raised to $266 from $250 at MizuhoIqvia price target raised to $266 from $250 at Mizuho

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jailendra Singh

Truist Financial

$290→$245

Buy

47.93%

Upside

Reiterated

02/19/26

Truist Financial Sticks to Its Buy Rating for IQVIA Holdings (IQV)

Charles Rhyee

TD Cowen

$245→$174

Hold

5.06%

Upside

Reiterated

02/13/26

IQVIA: Solid 2026 Outlook but AI Disruption Risks Justify Hold Rating and Lowered Valuation

Kallum Titchmarsh

Morgan Stanley

$265→$240

Buy

44.91%

Upside

Reiterated

02/11/26

Iqvia price target lowered to $240 from $265 at Morgan StanleyIqvia price target lowered to $240 from $265 at Morgan Stanley

Sean Dodge

BMO Capital

$250

Buy

50.95%

Upside

Reiterated

02/09/26

Analysts' Top Healthcare Picks: Haemonetics (HAE), Waters (WAT)

David Windley

Jefferies

$255

Buy

53.97%

Upside

Reiterated

02/06/26

Jefferies Reaffirms Their Buy Rating on IQVIA Holdings (IQV)

Dan Leonard

UBS

$280→$240

Buy

44.91%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $240 from $280 at UBSIqvia price target lowered to $240 from $280 at UBS

Shlomo Rosenbaum

Stifel Nicolaus

$273→$220

Buy

32.83%

Upside

Reiterated

02/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (NYSE: IQV), Qiagen (NYSE: QGEN) and Ligand Pharma (NASDAQ: LGND)

Patrick B Donnelly

Citi

$230→$200

Hold

20.76%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $200 from $230 at CitiIqvia price target lowered to $200 from $230 at Citi

Michael Ryskin

Bank of America Securities

$245

Buy

47.93%

Upside

Reiterated

02/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (NYSE: IQV), Ocular Therapeutix (NASDAQ: OCUL) and Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Anne Samuel

J.P. Morgan

$255→$225

Buy

35.85%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $225 from $255 at JPMorganIqvia price target lowered to $225 from $255 at JPMorgan

Luke Sergott

Barclays

$230→$210

Hold

26.80%

Upside

Reiterated

02/06/26

Barclays Keeps Their Hold Rating on IQVIA Holdings (IQV)

Elizabeth Anderson CFA

Evercore ISI

$250→$225

Buy

35.85%

Upside

Reiterated

02/06/26

Iqvia price target lowered to $225 from $250 at Evercore ISIIqvia price target lowered to $225 from $250 at Evercore ISI

Max Smock

William Blair

Buy

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Omnicell (NASDAQ: OMCL) and MiMedx Group (NASDAQ: MDXG)

David Larsen

BTIG

Hold

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Haemonetics (NYSE: HAE) and Denali Therapeutics (NASDAQ: DNLI)

Ann Hynes

Mizuho Securities

$250→$266

Buy

60.61%

Upside

Reiterated

01/09/26

Iqvia price target raised to $266 from $250 at MizuhoIqvia price target raised to $266 from $250 at Mizuho

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IQVIA Holdings

3 Months

xxx

Success Rate

22/32 ratings generated profit

Average Return

+3.02%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +3.02% per trade.

1 Year

David WindleyJefferies

Success Rate

21/32 ratings generated profit

Average Return

+6.53%

reiterated a buy rating 17 days ago

Copying David Windley's trades and holding each position for 1 Year would result in 65.63% of your transactions generating a profit, with an average return of +6.53% per trade.

2 Years

xxx

Success Rate

24/32 ratings generated profit

Average Return

+6.98%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +6.98% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IQV Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IQV has received 26 Buy Ratings, 18 Hold Ratings, and 0 Sell Ratings. IQV average Analyst price target in the past 3 months is 232.21.

Each month's total comprises the sum of three months' worth of ratings.

IQV Financial Forecast

IQV Earnings Forecast

Next quarter’s earnings estimate for IQV is $2.83 with a range of $2.78 to $2.88. The previous quarter’s EPS was $3.42. IQV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.

IQV Sales Forecast

Next quarter’s sales forecast for IQV is $4.10B with a range of $4.03B to $4.15B. The previous quarter’s sales results were $4.36B. IQV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.

IQV Stock Forecast FAQ

What is IQV’s average 12-month price target, according to analysts?

Based on analyst ratings, IQVIA Holdings Inc’s 12-month average price target is 232.21.

What is IQV’s upside potential, based on the analysts’ average price target?

IQVIA Holdings Inc has 40.21% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is IQV a Buy, Sell or Hold?

IQVIA Holdings Inc has a consensus rating of Strong Buy which is based on 12 buy ratings, 4 hold ratings and 0 sell ratings.

What is IQVIA Holdings Inc’s price target?

The average price target for IQVIA Holdings Inc is 232.21. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $266.00 ,the lowest forecast is $174.00. The average price target represents 40.21% Increase from the current price of $165.62.

What do analysts say about IQVIA Holdings Inc?

IQVIA Holdings Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of IQV?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

IQVIA Holdings (IQV) Stock Forecast & Price Target

IQV Analyst Ratings

IQV Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering IQVIA Holdings

IQV Analyst Recommendation Trends

IQV Financial Forecast

IQV Earnings Forecast

IQV Sales Forecast

IQV Stock Forecast FAQ

Detailed List of Analyst Forecasts